This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Hans Abeles, MD, MPH; Steven J. Farber, PA-C, JD; Julie Sarlo, PA-C
Albert Einstein College of Medicine of Yeshiva University Bronx, NY

JAMA. 1993;269(4):473-474.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—Selwyn et al¹ report important information for the prevention of tuberculosis in addicts infected with the human immunodeficiency virus (HIV). We would like to make the following comments based on our experience at the Albert Einstein College of Medicine Methadone Maintenance Clinic at Bronx (NY) Municipal Hospital Center, which was established 26 years ago specifically for the treatment of addicts with tuberculosis.

In 1985, we reported that 27% of our patients were positive for purified protein derivative (PPD) and 9% were anergic.² In 1989, again 97 (27%) of 355 patients who were tested were PPD-positive. Of these 97 patients, 20 (20%) had a history of treated tuberculosis. Of the remaining 77 PPD-positive patients, 61 (80%) had received preventive isoniazid treatment. Sixteen (20%) had no preventive treatment for one of the following reasons: they were HIV-negative and over 35 years of age; they had elevated, unstable . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?